New Fluoropolymer Micro Capillary Film to Launch at Medica

Capillary Film Technology Ltd (CFT), a technology and product development company for life sciences and clinical diagnostics, today announces that it will be launching a new fluoropolymer Micro Capillary Film (MCF) technology at Medica, which takes place from 20th to 23rd November at the Düsseldorf Fairgrounds, Germany.

In Hall 01 / D08 the company will demonstrate how a continuous, inexpensive MCF fluoropolymer is easily integrated into existing and emergent medical diagnostic immunoassay devices, to enable rapid, simultaneous quantitative measurement of multiple biomarkers (multiplexing) from a single sample.

Co-founder and Director of CFT, Dr Alexander Edwards explained: “We provide a viable fully quantitative multiplexed alternative to the commonly used lateral flow test strips approach that is used in many devices currently on the market.” 

Co-founder and Director of CFT, Dr Nuno Reis continued: “We will be presenting a disruptive manufacturing method for mass producing fluoropolymer microfluidic immunoassay devices. The parallel array of 200 micron internal diameter microcapillaries can deliver short assay times in a small disposable device that has outstanding optical properties suitable for existing colorimetric and fluorescent readouts.”

The CEO of CFT, Lee Smith added: “At Medica we look forward to showing established multinationals, small early stage organisations and healthcare providers, how we can significantly improve the capabilities and performance of their diagnostic products and biomarker tests, whether they are being used at the point of care, or within R&D. From our UK production facility we are able to adapt well established assay chemistry into a low-cost disposable microfluidic package, producing high-quality MCF on a massive scale to meet customer demand.”